RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) — Capital Reinvestment Ratio
Latest as of December 2024:
0.55x
RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has a Capital Reinvestment Ratio of 0.55x as of December 2024, meaning it reinvests 1% of its operating cash flow (€127.60 Million) in capital expenditures (€70.40 Million). See RHOEN-KLINIK.UNSP.ADR 1/2 free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.55x
Capex / Operating Cash Flow
Operating Cash Flow
€127.60 Million
EUR
Capital Expenditures
€70.40 Million
EUR
Data as of
Dec 2024
Most recent filing
RHOEN-KLINIK.UNSP.ADR 1/2 Capital Reinvestment Ratio (2021–2024)
This chart tracks RHOEN-KLINIK.UNSP.ADR 1/2's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)
Year-by-year Capital Reinvestment Ratio for RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024. For live market cap and broader valuation context, see RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | €127.60 Million | €70.40 Million | ▼ -4.2% |
| 2023 | 0.58x | €109.00 Million | €62.80 Million | ▼ -40.3% |
| 2022 | 0.97x | €60.30 Million | €58.20 Million | ▲ +21.0% |
| 2021 | 0.80x | €97.50 Million | €77.80 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow